Display options
Cite
Datta J, Rosemblit C, Berk E, et al. Progressive loss of anti-HER2 CD4. Oncoimmunology. 2015;4(10):e1022301doi: 10.1080/2162402X.2015.1022301.
Datta, J., Rosemblit, C., Berk, E., Showalter, L., Namjoshi, P., Mick, R., Lee, K. P., Brod, A. M., Yang, R. L., Kelz, R. R., Fitzpatrick, E., Hoyt, C., Feldman, M. D., Zhang, P. J., Xu, S., Koski, G. K., & Czerniecki, B. J. (2015). Progressive loss of anti-HER2 CD4. Oncoimmunology, 4(10), e1022301. https://doi.org/10.1080/2162402X.2015.1022301
Datta, Jashodeep, et al. "Progressive loss of anti-HER2 CD4." Oncoimmunology vol. 4,10 (2015): e1022301. doi: https://doi.org/10.1080/2162402X.2015.1022301
Datta J, Rosemblit C, Berk E, Showalter L, Namjoshi P, Mick R, Lee KP, Brod AM, Yang RL, Kelz RR, Fitzpatrick E, Hoyt C, Feldman MD, Zhang PJ, Xu S, Koski GK, Czerniecki BJ. Progressive loss of anti-HER2 CD4. Oncoimmunology. 2015 Apr 01;4(10):e1022301. doi: 10.1080/2162402X.2015.1022301. eCollection 2015 Oct. PMID: 26451293; PMCID: PMC4589053.
Copy Download .nbib Format: NLM
Share it on

Oncoimmunology. 2015 Apr 01;4(10):e1022301. doi: 10.1080/2162402X.2015.1022301. eCollection 2015 Oct.

Progressive loss of anti-HER2 CD4.

Oncoimmunology

Jashodeep Datta, Cinthia Rosemblit, Erik Berk, Lori Showalter, Prachi Namjoshi, Rosemarie Mick, Kathreen P Lee, Andrew M Brod, Rachel L Yang, Rachel R Kelz, Elizabeth Fitzpatrick, Clifford Hoyt, Michael D Feldman, Paul J Zhang, Shuwen Xu, Gary K Koski, Brian J Czerniecki

Affiliations

  1. Department of Surgery; University Pennsylvania Perelman School of Medicine ; Philadelphia, PA USA.
  2. Department of Biological Sciences; Kent State University ; Kent, OH USA.
  3. Department of Epidemiology and Biostatistics; University of Pennsylvania Perelman School of Medicine ; Philadelphia, PA USA.
  4. Department of Surgery; Stanford University Hospital and Clinics ; Palo Alto, CA USA.
  5. Life Sciences & Technology; PerkinElmer Inc. ; Hopkinton, MA USA.
  6. Department of Pathology; University of Pennsylvania Perelman School of Medicine ; Philadelphia, PA USA.
  7. Department of Surgery; University Pennsylvania Perelman School of Medicine ; Philadelphia, PA USA ; Rena Rowen Breast Center; Hospital of the University of Pennsylvania ; Philadelphia, PA USA.

PMID: 26451293 PMCID: PMC4589053 DOI: 10.1080/2162402X.2015.1022301

Abstract

Genomic profiling has identified several molecular oncodrivers in breast tumorigenesis. A thorough understanding of endogenous immune responses to these oncodrivers may provide insights into immune interventions for breast cancer (BC). We investigated systemic anti-HER2/

Keywords: CD4+ T-helper immunity; HER2/neu; breast cancer; dendritic cell; immune monitoring; immune restoration; vaccination

References

  1. J Am Coll Surg. 2002 Apr;194(4):488-501 - PubMed
  2. Cancer Res. 2013 Mar 1;73(5):1635-46 - PubMed
  3. Clin Cancer Res. 2009 Apr 15;15(8):2895-904 - PubMed
  4. Cancer. 2012 Sep 1;118(17):4354-62 - PubMed
  5. PLoS One. 2013;8(2):e57114 - PubMed
  6. N Engl J Med. 2005 Oct 20;353(16):1659-72 - PubMed
  7. Future Oncol. 2012 Oct;8(10):1273-99 - PubMed
  8. Mol Cell Biochem. 2011 Jan;347(1-2):41-51 - PubMed
  9. N Engl J Med. 2012 Jun 28;366(26):2443-54 - PubMed
  10. Nat Rev Clin Oncol. 2011 Aug 02;8(10):577-85 - PubMed
  11. Oncogene. 1990 Jul;5(7):953-62 - PubMed
  12. J Clin Oncol. 2011 May 20;29(15):1949-55 - PubMed
  13. Nature. 2000 Aug 17;406(6797):747-52 - PubMed
  14. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):845-53 - PubMed
  15. Cancer Res. 2004 Nov 1;64(21):8022-8 - PubMed
  16. Front Oncol. 2014 Sep 29;4:266 - PubMed
  17. Blood. 2005 Feb 1;105(3):1162-9 - PubMed
  18. Cancer Res. 2007 Nov 15;67(22):10669-76 - PubMed
  19. Annu Rev Immunol. 1993;11:331-60 - PubMed
  20. N Engl J Med. 2010 Aug 26;363(9):809-19 - PubMed
  21. Cancer Res. 2010 Nov 1;70(21):8368-77 - PubMed
  22. Cancer Immunol Immunother. 2008 Dec;57(12):1817-25 - PubMed
  23. Mol Med Rep. 2012 Oct;6(4):779-82 - PubMed
  24. Mol Syst Biol. 2006;2:54 - PubMed
  25. BMC Immunol. 2008 Mar 17;9:9 - PubMed
  26. J Immunother. 2012 Jan;35(1):54-65 - PubMed
  27. Clin Cancer Res. 2009 Dec 15;15(24):7479-7491 - PubMed
  28. Cancer Res. 2001 Feb 1;61(3):880-3 - PubMed
  29. J Clin Invest. 2013 Jul;123(7):2873-92 - PubMed
  30. J Immunol. 2002 Sep 1;169(5):2756-61 - PubMed
  31. CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 - PubMed
  32. Sci Transl Med. 2011 Aug 10;3(95):95ra73 - PubMed
  33. N Engl J Med. 2010 Jul 29;363(5):411-22 - PubMed
  34. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1386-9 - PubMed
  35. J Immunol Methods. 2003 Aug;279(1-2):111-21 - PubMed
  36. Oncogene. 2006 Nov 2;25(52):6986-96 - PubMed
  37. Clin Cancer Res. 1999 Jun;5(6):1289-97 - PubMed

Publication Types

Grant support